JPRN-UMIN000013204
Completed
未知
Randomized control trial of transarterial chemoembolization with miriplatin-lipiodol suspension or drug eluting bead with doxorubicin for hepatocellular carcinoma - Randomized control trial of transarterial chemoembolization with miriplatin-lipiodol suspension or drug eluting bead with doxorubicin for hepatocellular carcinoma
Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Aichi, Japan0 sites56 target enrollmentMay 30, 2014
Conditionshepatocellular carcinoma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- hepatocellular carcinoma
- Sponsor
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Aichi, Japan
- Enrollment
- 56
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Having metastasis. 2\)Having vascular invasion. 3\)Having vascular anormality or AP shunt. 4\)Having previous treatment with miriplatin or DC bead. 5\)Having previous treatment with sorafenib. 6\)Having severe ascites or pleural effusion. 7\)Considered as HCC refractory for TACE. 8\)Having allergy of contrast agent. 9\)Having severe renal failure. 10\)Having severe cardiac disease. 11\)Having other cancer. 12\)Having hemorrhagic varix. 13\)Having severe mental disorder. 14\)Having severe drug allergy. 15\)Having possibility of pregnant or nursing. 16\)Deemed inappropriate to perform the study by the physician.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Randomized Controlled Trial of Transcatheter Arterial Chemoembolization for Hepatocellular CarcinomaHepatocellular CarcinomaJPRN-UMIN000001384ACE 500 Study Group450
Completed
Not Applicable
A randomized controlled trial of transcatheter arterial chemoembolization(TACE) in patients with advanced hepatocellular:Comparison of periodical TACE versus recurrence time TACEadvanced hepatocellular carcinoma(HCC)JPRN-UMIN000000690Department of Clinical Research, National Hospital Organization Iwakuni Clinical Center78
Completed
Phase 2
Phase II trial of Transarterial Chemoembolization using Drug-eluting bead for advanced HCC refractory to Lipiodol-TACEadvanced hepatocellular carcinomaJPRN-UMIN000015463Clinical Research Group of the Japanese Society for Transcatheter Hepatic Arterial Embolization24
Active, not recruiting
Not Applicable
Strain sUrveillance during Chemotherapy for improving Cardiovascular OUtcomesACTRN12614000341628Menzies Research Institute Tasmania331
Recruiting
Not Applicable
A Randomized Clinical Trial of Transcatheter Arterial Infusion (TAI) appending to Radio Frequency Ablation Therapy for Hepatocellular CarcinomaHepatocellular CarcinomaJPRN-UMIN000008253Kyoundo Hospital90